7M. Naves,M. Rodríguez-García,J. B. Díaz-López,C. Gómez-Alonso,J. B. Cannata-Andía.Progression of vascular calcifications is associated with greater bone loss and increased bone fractures[J]. Osteoporosis International . 2008 (8)
8Y. Z. Bagger,H. B. Rasmussen,P. Alexandersen,T. Werge,C. Christiansen,L. B. Tankó.Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?[J]. Osteoporosis International . 2007 (4)
9Samy I. McFarlane MD, FACP,Ranganath Muniyappa,John J. Shin,Gul Bahtiyar,James R. Sowers.Osteoporosis and cardiovascular disease[J]. Endocrine . 2004 (1)
10E. I. Barengolts,M. Berman,S. C. Kukreja,T. Kouznetsova,C. Lin,E. V. Chomka.Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal Women[J]. Calcified Tissue International . 1998 (3)
4Schulz E, Arfai K, Liu XD, et al. Aortic calcification and the risk of osteoporosis and fractures [ J ]. J Clini Endocrinol Metab,2004,89 (9) :4246-4253.
5Tanko LB,Christiansen C,Cox DA,et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women[J]. J Bone Miner Res,2005,20( 11 ):1912-1920.
6Hak AE, Pols HA, van Hemert AM,et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause : A population-based longitudinal study [ J ]. Arterioscler Thromb Vasc Biol,2000,20( 8 ) : 1926-1931.
7Abedin M, Tintut Y, Demer LL, et al. Vascular calcification: mechanisms and clinical ramifications [ J ]. Arterioscler Thromb Vasc Biol,2004,24 (7) : 1161-1170.
8Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation[J]. Arterioscler Thromb Vasc Biol, 1997,17(4) :680-687.
9Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient micedevelop early onset osteoporosis and arterial calcification[ J]. Gene & Development, 1998,12(9) : 1260-1268.
10Min H, Morony S, Sarosi I, et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling os teoclastogenesis[ J]. J Exp Med,2000,192(4) :463-474.
5Lacey DL, Boyle WJ, Simonet WS,sey, et al. Bench to bedside:elucidation of the OPG-RANK-RANKL pathway and the develop-ment of denosumab[ J]. Nat Rev Drug Discov,2012,11:401 -419.
